DNMT and TET Knockout Cell Lines: Phenotypes and Verification

Almost every methylation study needs a context in which the machinery is defined. DNMT knockouts remove the writing or maintenance of 5mC; TET knockouts remove the oxidation pathway that leads to demethylation. Together they provide the minimal set of backgrounds for asking whether a methylation change is caused by a specific enzyme.

The trouble is that these are not clean single-function knockouts. DNMT1 loss destabilizes the genome and perturbs differentiation; DNMT3A and 3B have overlapping and non-overlapping targets; TET loss produces hypermethylation that can itself alter proliferation. Each line comes with a phenotype that must be characterized before it is used as a "neutral" background.

This article maps expected phenotypes, verification steps, and the interpretation traps. The editor comparison and general validation logic live in our pillar on epigenome editing.

Two expectations deserve emphasis because they are frequently mis-stated: DNMT1 loss is not an instantaneous global erasure — methylation decays over divisions, so a clone at passage 5 differs from the same clone at passage 20. And TET loss does not simply mirror DNMT loss: hypermethylation after TET loss is progressive and locus-selective.

Verification has four layers, and most published lines are only checked at the first.

1. Edit confirmation. Junction sequencing or amplicon NGS, zygosity by digital PCR. For compound knockouts, confirm each allele of each gene.
2. Protein absence. Western blot with a validated antibody, or targeted proteomics. mRNA absence is insufficient: feedback and truncating alleles can produce detectable protein fragments.
3. Enzyme-activity phenotype. This is the layer that matters biologically: global 5mC by LUMA or HPLC, locus-specific methylation by bisulfite/EM-seq, and 5hmC by dot blot or antibody-based capture for TET lines. A DNMT1 knockout with unchanged global methylation is either recently derived, or not a knockout.
4. Functional context. Proliferation, morphology, and the differentiation capacity relevant to your downstream experiment — because a background that cannot differentiate cannot be used to study differentiation-linked methylation.

The fourth row is the practical trap: laboratories often derive a single clone and then generalize. Two independent clones per genotype, verified identically, is the minimum for any phenotype claim.

Three design rules when a DNMT or TET knockout is the platform rather than the subject:

• • Match passage. A methylation background drifts; compare edited and control cells at matched passages, and report them.
• • Check the mark you are about to interpret. If your experiment reads promoter methylation, confirm the background's methylation state at that promoter before editing.
• • Do not treat the knockout as neutral. Global methylation loss changes chromatin, repeat silencing, and interferon responses in some systems; any phenotype attributed to your targeted edit should be compared against the knockout background with the same guide but a dead effector.

The last rule is what separates "the mark at this locus matters" from "the whole methylome changed".

Reporting this table takes half a page and pre-empts the most common reviewer objection to methylation-background papers.

EDITGENE supplies DNMT1, DNMT3A/3B and TET1/2 knockout lines with junction sequencing, zygosity by digital PCR, protein-absence confirmation, global 5mC/5hmC measurements, and matched parental controls at defined passages.

Tell us the gene and the downstream assay. Contact EDITGENE to request a project consultation or quote.

Phenotypes described here summarize commonly reported observations; severity and penetrance vary by cell type, passage, and derivation method, and some lines carry adaptations that mask expected phenotypes.

A knockout used as a background must be verified at genotype, protein, and mark level, and its phenotype reported rather than assumed neutral.

• • Okano M, et al. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 1999;99:247–257.
• • Li E, et al. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell. 1992;69:915–926.
• • Ito S, et al. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature. 2010;466:1129–1133.
• • Greenberg MVC, Bourc'his D. The diverse roles of DNA methylation in mammalian development and disease. Nature Reviews Molecular Cell Biology. 2019;20:590–607.
• • Karagiannis P, et al. Assessing DNA methylation levels in animals: choosing the right tool for the job. Animal Reproduction. 2015;12:1–9.